Top contributors in Q2 were SPOK Holdings (SPOK), OTC Markets (OTCM), and Ligand Pharmaceuticals (LGND). SPOK reported solid Q1 results in April, and 2025 guidance appears conservative. OTCM returned ...
*Inception date is 3/31/2007 for Large Cap, Small Cap, and Focus Plus Composites. Inception date is 11/30/2007 for Focus Composite. Inception date is 4/1/2011 for All Cap Composite. Past performance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback